Investor directory4BIO Capital
4BIO Capital invests in early-stage life sciences companies focused on advanced therapies.
What they invest in
Sectors
Geographies
In numbers
In the last 24 months, 4BIO Capital took part in 3 funding rounds on record at Oka, all of them in the last 12 months. Biotech & Pharma is its most frequent sector (3 of 3 rounds with a known sector). The most recent round on record is from October 2026.
As of October 2026. Source: Oka, counted from funding rounds reported in the press; rounds that were never reported are not included.
The facts
- Typical cheque
- €1M – €30M
- Headquarters
- London, United Kingdom
- Founded
- 2014
Portfolio companies
More portfolio companies
Recent rounds
Aptadir Therapeutics
$45MSeedBiotech & Pharma4BIO CapitalleadCDP Venture CapitalXGEN VENTURECE VenturesINDACOAngelini Ventures · +4 more in the source
Italytech.eu
Rounds 4BIO Capital took part in, as reported by the linked articles. See who else is investing right now.
Questions founders ask
- Is 4BIO Capital actively investing?
- Yes. Oka has 3 funding rounds with 4BIO Capital on record from the last 12 months; the most recent is from October 2026.
- How much does 4BIO Capital typically invest?
- 4BIO Capital states a typical cheque of €1M – €30M.
- Which stages does 4BIO Capital invest in?
- 4BIO Capital invests at Seed, Series A and Series B.
- Where is 4BIO Capital based?
- 4BIO Capital is headquartered in London, United Kingdom.
Does 4BIO Capital fit your round?
In 30 minutes you'll know which funds matter for your round.
Get a demoSearch investors like this in Claude — no account, no sign-in. Open in Claude
Are you 4BIO Capital? Tell us what to correct and we will update it — or ask us to remove the entry.